by tlogan | Sep 19, 2022 | Press Release
Phosphorex Appoints Jarlath Keating as Chief Executive Officer Hopkinton, MA, September 19, 2022 – Following the recent growth capital investment from Ampersand Capital Partners, Phosphorex, a drug delivery-focused contract development and manufacturing organization...
by tlogan | Aug 25, 2022 | Press Release
Phosphorex to Establish cGMP Manufacturing for Lipid Nanoparticles with Growth Capital from Ampersand Hopkinton, MA, August 25, 2022 – Phosphorex, a drug delivery-focused contract development and manufacturing organization providing microspheres and polymer and lipid...
by tlogan | Feb 16, 2022 | Press Release
Phosphorex and Dolomite Host Collabarative Webinar to Share Their Insights on Making Liposomes and Lipid Nanoparticles (LNPs) with Microfluidics Hopkinton, MA, Feburary 16, 2022 – Phosphorex & Dolomite experts Dr. Julia Rashba-Step, Dr. Cate O’Brien, Dr. Nicholas...
by tlogan | Aug 11, 2021 | Article, Press Release
Phosphorex and Dolomite Jointly Publish Articles to Discuss How Automation Benefits Development and Production of Lipid Nanoparticles (LNPs) Hopkinton, MA, August 11, 2021 – Dr. Julia Rashba-Step, Phosphorex’ Vice President of R&D and Alliance Management,...
by tlogan | Jul 27, 2021 | Press Release
Phosphorex Presents Its Nanosuspension Formulation at CRS Meeting Hopkinton, MA , July 27, 2021 – Dr. Bin Wu, Phosphorex’ President and CEO, today presented “A Novel Indirubin Nanosuspension for Potential Treatment of Glioblastoma” at the 2021 Controlled Release...
Recent Comments